Plant-derived compounds best known for their antimalarial properties relieve polycystic ovary syndrome, a major public health problem that affects millions of women worldwide. These compounds, called artemisinins, achieve their affect by suppressing ovarian androgen production in multiple rodent models as well as in a small cohort of human patients, according to a new study. The findings not only underscore the versatility of artemisinins but reveal a promising new approach for preventing and treating the disorder.
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. It is characterized by elevated androgen levels (hyperandrogenemia) and associated with a wide range of health impacts, including metabolic dysfunction, impaired ovulation, and often infertility. However, despite the high prevalence of the syndrome, the mechanistic basis of PCOS is poorly understood, and drug treatments often focus only on specific symptoms with limited effectiveness.
Because hyperandrogenemia is the main feature and cause of most PCOS-associated symptoms and comorbidities, treatments aimed at suppressing androgen production could be beneficial in treating PCOS.
Here, the researchers evaluated the effect of artemisinin and its derivatives on PCOS development. While better known for their antimalarial effects, these compounds have also been shown to have beneficial metabolic effects.
In rodent models, the authors found that artemether (ATM), an artemisinin derivative isolated from Artemisia plants, reduces ovarian androgen synthesis by targeting CYP11A1, a crucial enzyme in androgen production.
ATM induces CYP11A1 degradation by enhancing its interaction with the protease LONP1. And, LONP1 overexpression, the authors found, suppresses ovarian androgen production.
In a pilot clinical study of 19 women with PCOS, the authors further demonstrated the therapeutic potential of artemisinin. For these women, taking dihydroartemisinin – a drug used to treat malaria – for 12 weeks substantially reduced key PCOS biomarkers and led to more regular menstrual cycles without side effects.
“Although further studies will be needed to fully understand the long-term effects and to optimize dosing strategies to maximize therapeutic outcomes, the discovery of artemisinins as effective remedies for PCOS nonetheless represents a promising new approach for the development of specific therapies that will potentially change the landscape of PCOS treatment,” writes an author in a related Perspective.
Latest News
Bidirectional BCI functiona…
By newseditor
Posted 19 Jun
Protein aggregation clock t…
By newseditor
Posted 19 Jun
A new protein in pathologic…
By newseditor
Posted 19 Jun
How cells and tissues age?
By newseditor
Posted 19 Jun
Kainate receptor channel op…
By newseditor
Posted 19 Jun
Other Top Stories
Sex cells have a sweet tooth, and they pass it on to the brain
Read more
Elderly people protected against respiratory infections by BCG vac…
Read more
How Can Hearing Loss Cause Dementia?
Read more
Cells 'suicide' gene linked to ineffective immunotherapy
Read more
AMPK is a key regulator of neuronal function and survival
Read more
Protocols
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Analysis of 3D pathology sa…
By newseditor
Posted 08 Jun
Long-term expandable mouse…
By newseditor
Posted 07 Jun
Publications
Embryos burn fat in standby
By newseditor
Posted 20 Jun
Systemic immune challenge e…
By newseditor
Posted 20 Jun
Transcranial focused ultras…
By newseditor
Posted 19 Jun
Adding intrinsically disord…
By newseditor
Posted 19 Jun
Aplp1 interacts with Lag3 t…
By newseditor
Posted 19 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar